Medpace Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Medpace Holdings, Inc. (MEDP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 12.72 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-02-10
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2021-03-31 was 12.00K shares, a 68.50% decline year-over-year.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2020-12-31 was 36.74K shares, a 32.92% increase year-over-year.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2020-09-30 was 29.57K shares, a 88.43% decline year-over-year.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2020-06-30 was 14.48K shares, a 69.39% decline year-over-year.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 12.72K shares, a 99.47% increase from fiscal 2024.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 6.38K shares, a 43.31% decline from fiscal 2023.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 11.25K shares, a 69.47% decline from fiscal 2022.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 36.85K shares, a 17.80% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 12.72K shares 10-K · filed 2026-02-10 | |||
| 2024-12-31 | 6.38K shares 10-K · filed 2026-02-10 | |||
| 2023-12-31 | 11.25K shares 10-K · filed 2026-02-10 | |||
| 2022-12-31 | 36.85K shares 10-K · filed 2025-02-11 | |||
| 2021-12-31 | 44.83K shares 10-K · filed 2024-02-13 | |||
| 2021-03-31 | 12.00K shares 10-Q · filed 2021-04-27 | 48.74K shares derived: sum of 2 quarters · filed 2023-02-14 | 78.31K shares derived: sum of 3 quarters · filed 2023-02-14 | 92.79K shares derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | 36.74K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | 66.31K shares derived: sum of 2 quarters · filed 2023-02-14 | 80.79K shares derived: sum of 3 quarters · filed 2023-02-14 | 118.89K shares 10-K · filed 2023-02-14 |
| 2020-09-30 | 29.57K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | 44.05K shares derived: sum of 2 quarters · filed 2020-10-27 | 82.15K shares 10-Q · filed 2020-10-27 | 109.79K shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2020-06-30 | 14.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | 52.58K shares 10-Q · filed 2020-07-28 | 80.22K shares derived: sum of 3 quarters · filed 2021-02-16 | 335.73K shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2020-03-31 | 38.10K shares 10-Q · filed 2020-04-29 | 65.74K shares derived: sum of 2 quarters · filed 2021-02-16 | 321.25K shares derived: sum of 3 quarters · filed 2021-02-16 | 368.56K shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-12-31 | 27.64K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | 283.15K shares derived: sum of 2 quarters · filed 2021-02-16 | 330.46K shares derived: sum of 3 quarters · filed 2021-02-16 | 375.56K shares 10-K · filed 2021-02-16 |
| 2019-09-30 | 255.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | 302.82K shares derived: sum of 2 quarters · filed 2019-10-29 | 347.92K shares 10-Q · filed 2019-10-29 | 388.06K shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | 47.31K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | 92.41K shares 10-Q · filed 2019-07-30 | 132.55K shares derived: sum of 3 quarters · filed 2021-02-16 | 214.00K shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | 45.10K shares 10-Q · filed 2019-04-30 | 85.24K shares derived: sum of 2 quarters · filed 2021-02-16 | 166.69K shares derived: sum of 3 quarters · filed 2021-02-16 | 235.09K shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | 40.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | 121.60K shares derived: sum of 2 quarters · filed 2021-02-16 | 190.00K shares derived: sum of 3 quarters · filed 2021-02-16 | 252.36K shares 10-K · filed 2021-02-16 |
| 2018-09-30 | 81.46K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | 149.86K shares derived: sum of 2 quarters · filed 2018-10-30 | 212.22K shares 10-Q · filed 2018-10-30 | 291.57K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | 68.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | 130.76K shares 10-Q · filed 2018-07-31 | 210.12K shares derived: sum of 3 quarters · filed 2020-02-25 | 309.46K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | 62.36K shares 10-Q · filed 2018-05-01 | 141.72K shares derived: sum of 2 quarters · filed 2020-02-25 | 241.06K shares derived: sum of 3 quarters · filed 2020-02-25 | |
| 2017-12-31 | 79.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | 178.70K shares derived: sum of 2 quarters · filed 2020-02-25 | 304.41K shares 10-K · filed 2020-02-25 | |
| 2017-09-30 | 99.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | 225.05K shares 10-Q · filed 2017-10-31 | ||
| 2017-06-30 | 125.71K shares 10-Q · filed 2017-08-01 | |||
| 2016-12-31 | 90.56K shares 10-K · filed 2019-02-26 | |||
| 2015-12-31 | 168.78K shares 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |